skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Download Your Report Extract

December 1 is World AIDS Day, dedicated to raising awareness of the worldwide AIDS pandemic caused by the spread of HIV infection. To commemorate the occasion, Informa Pharma Intelligence is offering a free download of the GlaxoSmithKline: Company Analysis report extract from Datamonitor Healthcare.

In it, PharmaVitae explores GlaxoSmithKline’s prescription pharmaceutical performance and outlook over 2017–27, which is highly dependent on successful uptake of two-drug regimens in HIV such as Juluca, cabotegravir/rilpivirine, and Tivicay/Epivir to drive growth.

The GlaxoSmithKline: Company Analysis extract contains vital information about GSK’s Q2 2018 review, including:

  • A detailed look at GSK’s HIV portfolio which grew despite increased competition from Gilead
  • GSK’s new $300m partnership with genomic data company 23andMe
  • Shifts in GSK’s respiratory portfolio
  • Details on GlaxoSmithKline’s push to simplify HIV treatment regimens by pushing its two-drug treatments to market
  • Opportunities, threats, and upcoming key events and catalysts
World AIDS Day Glaxosmithkiline report extract

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。